Cited by 88Barrier Structure and Function StudiesHIV Research and TreatmentNeuroinflammation and Neurodegeneration Mechanisms

Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS

Open access
Buckner, Clarisa M., Luers, Aimée J., Calderon, Tina M., Eugenin, Eliseo A., Berman, Joan W.·2006·Journal of Neuroimmune Pharmacology

Abstract

HIV infection of the central nervous system (CNS) can result in neurologic dysfunction with devastating consequences in a significant number of individuals with AIDS. Two main CNS complications in individuals with HIV are encephalitis and dementia, which are characterized by leukocyte infiltration into the CNS, microglia activation, aberrant chemokine expression, blood-brain barrier (BBB) disruption, and eventual damage and/or loss of neurons. One of the major mediators of NeuroAIDS is the transmigration of HIV-infected leukocytes across the BBB into the CNS. This review summarizes new key findings that support a critical role of the BBB in regulating leukocyte transmigration. In addition, we discuss studies on communication among cells of the immune system, BBB, and the CNS parenchyma, and suggest how these interactions contribute to the pathogenesis of NeuroAIDS. We also describe some of the animal models that have been used to study and characterize important mechanisms that have been proposed to be involved in HIV-induced CNS dysfunction. Finally, we review the pharmacologic interventions that address neuroinflammation, and the effect of substance abuse on HIV-1 related neuroimmunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11481-006-9017-3

Cites

261 of 261 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The brain inflammatory response to antigen infiltration triggered by activated microglia may result in aberrant expression of several chemokines, leading to alterations in BBB permeability.

    “the brain inflammatory response to antigen infiltration (virus, bacteria or fungus) triggered by activated microglia may result in aberrant expression of several chemokines, leading to alterations in BBB permeability (Buckner et al., 2006; Obermeier et al., 2013).”

    From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Buckner et al., 2006

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Benagiano V, Virgintino D, Maiorano E, Rizzi A, Palombo S, Roncali L, Ambrosi G. VIP-like immunoreactivity within neurons and perivascular neuronal processes of the human cerebral cortex. Eur J Histochem. 1996;40:53–56. [PubMed] [Google Scholar]
  2. Zink MC, Clements JE. A rapid, reproducible model of AIDS and encephalitis in SIV infected macaques demonstrates the role of viral load in CNS disease. NeuroAIDS. 2000;3 Online AAAS Science publication http://AIDScience.org/NeuroAIDS/ [Google Scholar]

Cited by

Sorted by citations

Authors
Buckner, C. M., Luers, A. J., Calderon, T. M., Eugenin, E. A., & Berman, J. W.
Affiliations
Albert Einstein College of Medicine (US)
Corresponding author
Berman, Joan W.
Venue
Journal of Neuroimmune Pharmacology
Published
2006-04-13
Volume
1
Issue
2
Pages
160-181
ISSN
  • 1557-1890 (ISSN-L)
  • 1557-1904
OpenAlex
W2018506622
Cited by
88
References
260
Citations by year
2026: 1 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 7 · 2014: 6 · 2013: 2 · 2012: 8
FWCI
3.51
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroimmune Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01mh052974-10)
  • Center for AIDS Research, University of Washington
  • National Institute of Mental Health (K01MH076679, MH0702297, R01MH075679, MH 52974)
  • National Institute of Allergy and Infectious Diseases (P30AI051519, AI 051519)
  • National Institute of Neurological Disorders and Stroke (T32NS007098, NS-11920, P50NS011920, NS 07098)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
neuroimmunity, blood-brain barrier, HIV infection, neuroAIDS, leukocyte transmigration, HIV-associated encephalitis, HIV-associated dementia, microglial activation, chemokines, neuroinflammation, substance abuse, animal models of HIV, pharmacological interventions
MeSH terms
Acquired Immunodeficiency Syndrome, Animals, Blood-Brain Barrier, Brain, Chemotaxis, Leukocyte, Humans, Neuroimmunomodulation, HIV-1, AIDS Dementia Complex, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review